Accordant Advisory Group Inc Bristol Myers Squibb CO Transaction History
Accordant Advisory Group Inc
- $104 Billion
- Q4 2024
A detailed history of Accordant Advisory Group Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Accordant Advisory Group Inc holds 580 shares of BMY stock, worth $32,567. This represents 0.03% of its overall portfolio holdings.
Number of Shares
580
Previous 580
-0.0%
Holding current value
$32,567
Previous $30 Million
9.32%
% of portfolio
0.03%
Previous 0.02%
Shares
1 transactions
Others Institutions Holding BMY
# of Institutions
2,690Shares Held
1.53BCall Options Held
32MPut Options Held
35.4M-
Vanguard Group Inc Valley Forge, PA190MShares$10.7 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.91 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.39 Billion0.44% of portfolio
-
State Street Corp Boston, MA92.9MShares$5.22 Billion0.2% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.39 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $119B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...